Schedule a Pancreatic Cyst Evaluation
Seek specialist review after a new cyst is found, especially when the report does not clearly describe type, size, duct connection, or follow-up.
- Bring all prior imaging
- Ask for pancreas-focused review
GastroDoxs helps patients understand whether a pancreatic cyst needs MRI surveillance, EUS and fluid testing, shorter follow-up, or pancreatic-surgery review.
Pancreatic cyst treatment ranges from planned surveillance to EUS-guided evaluation and surgery for selected high-risk lesions. GastroDoxs GutRescue Mission™ connects cyst type, size, growth, duct communication, mural nodules, pancreatitis, jaundice, fluid results, age, health, and surgical fitness into a personalized management plan.
Treatment-stage care connects the diagnosis with practical options, safety review, monitoring, and specialist coordination.
We compare every available MRI, MRCP, CT, and prior report to identify cyst type, growth, duct changes, nodules, and other risk features.
We determine whether endoscopic ultrasound and cyst-fluid or tissue sampling is likely to change the treatment plan.
We set follow-up according to cyst type, size, growth, symptoms, age, overall health, and whether surgery would be considered if the cyst changes.
We coordinate multidisciplinary review for cysts with high-risk features, concerning cytology, main-duct involvement, or significant symptoms.
A clear path from scheduling and records review to a personalized treatment plan.
Share your current pancreatic cysts symptoms, diagnosis, treatment history, goals, and the questions you need answered.
Bring all prior CT, MRI, MRCP, ultrasound, and EUS images and reports; cyst-fluid and cytology results; pancreatitis history; family cancer history; laboratory tests; and details about jaundice, weight loss, or new diabetes.
A GastroDoxs GI specialist reviews the diagnosis, treatment options, safety factors, expected benefits, and whether another specialist or procedure is needed.
Your pancreatic cysts plan may include medication, nutrition, lifestyle care, testing, a procedure, monitoring, or coordinated referral.
Your guardians. GastroDoxs GutGuardians™ is an elite team of board-certified gastroenterologists - a physician-led defense force of specialists, systems, and solution pathways working together to protect, detect, solve, and defend your digestive health through expert GI evaluation, advanced diagnostic screening, and endoscopic evaluation - commanded from your first concern to your last follow-up, and every critical stage in between.
Your rescue plan. When your diagnosis is confirmed, GastroDoxs GutRescue Mission™ deploys at full force - a gastroenterologist-led intervention plan delivering advanced colonoscopy, upper endoscopy, capsule endoscopy, and precision biologic and medication management across the full range of digestive conditions and complex GI emergencies - fighting for you with everything we have.
Schedule non-emergency care when you need treatment selection, reassessment, monitoring, or specialist coordination.
Seek specialist review after a new cyst is found, especially when the report does not clearly describe type, size, duct connection, or follow-up.
MRI or MRCP is often repeated at an interval based on cyst size, type, growth, risk features, age, and health.
Schedule review when a cyst grows, develops a nodule or duct change, causes pancreatitis or jaundice, or has no clearly documented surveillance plan.
Surveillance may be reconsidered when a benign diagnosis is secure, life expectancy or surgical fitness changes, or follow-up would not alter care.
Pancreatic cyst management should balance cyst type and cancer-risk features with age, health, surgical fitness, patient goals, procedure risk, and the value of continued surveillance.
GastroDoxs provides patient-facing treatment planning for pancreatic cysts, including records review, medication and procedure questions, symptom monitoring, insurance guidance, and coordinated referral when another specialist is needed.
Treatment depends on cyst type and risk. Most low-risk cysts are monitored with MRI or MRCP, while EUS and fluid testing clarify uncertain lesions. Surgery is considered for high-risk, precancerous, cancerous, or significantly symptomatic cysts.
No. Many pancreatic cysts have a low immediate cancer risk and are managed with planned surveillance. Surgery is reserved for selected cysts where expected cancer-prevention or symptom benefit outweighs operative risk.
Doctors consider cyst type, size, growth, duct communication, mural nodules, solid components, symptoms, pancreatitis, jaundice, cytology, molecular results, age, medical fitness, and patient goals.
Monitoring is appropriate when the cyst lacks high-risk features and the patient would consider treatment if concerning changes appear. The interval depends on type, size, growth, age, and health.
Concerning signs include obstructive jaundice, an enhancing mural nodule or solid component, main-duct dilation, rapid growth, recurrent pancreatitis, concerning cytology, weight loss, or new diabetes.
Yes. Surveillance is the main non-surgical approach for many cysts. EUS can clarify risk, and endoscopic drainage may treat selected pseudocysts or fluid collections, but it does not remove most precancerous cysts.
EUS provides high-resolution imaging of the cyst and nearby duct and can obtain fluid or tissue when results may change management. It helps decide between surveillance, shorter follow-up, or surgery.
Surgery is recommended when high-risk features, concerning cytology, main-duct involvement, selected mucinous cysts, cancer suspicion, or significant cyst-related symptoms make the expected benefit greater than operative risk.
Precancerous cysts are managed according to their estimated risk. Lower-risk lesions undergo surveillance, while high-risk IPMNs, mucinous cystic neoplasms, or lesions with concerning changes may be surgically removed.
Appropriate surveillance can detect concerning change before invasive cancer develops, and surgery can remove selected high-risk precancerous cysts. No strategy eliminates all risk.
Intervals vary from months to years depending on cyst type, size, stability, risk features, age, health, and guideline approach. The schedule should be documented and updated after every scan.
Recovery depends on the operation and may involve hospital care, pain control, gradual diet advancement, blood-sugar monitoring, pancreatic enzyme treatment, and several weeks to months of recovery.
Doctors compare imaging over time, monitor symptoms and duct changes, review pathology after surgery, and use EUS, fluid testing, laboratory results, or cancer surveillance when clinically indicated.
Avoid smoking, limit alcohol, maintain a healthy weight, control diabetes and triglycerides, follow a balanced diet, and seek prompt care for pancreatitis symptoms. Lifestyle changes do not make a neoplastic cyst disappear.
A specialist combines all imaging, EUS and fluid results, pancreatitis and family history, age, medical fitness, cancer risk, and patient preferences to choose surveillance, additional testing, or surgery.
Book a GastroDoxs pancreatic-cyst evaluation for a new or growing cyst, unclear imaging, EUS questions, pancreatitis, risk-feature review, surveillance planning, or surgical coordination.